Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Salubris Biotherapeutics Inc
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants with HF New York Heart Association Class II-III.
Participants will be classified as having HFrEF (LVEF ≤ 40%) or HFpEF (LVEF \>40% and ≤70%).
Right heart catheterization (RHC) based evidence of cpcPH:
PVR ≥2.5 WU; AND
mPAP ≥25 mmHg; AND
PAWP ≥16 mmHg
You may not be if
Diagnosis of PH in World Health Organization (WHO) Group 1, WHO Group 3, WHO Group 4, or WHO Group 5.
Contraindicated to RHC that can be left in place for approximately 6 hours.
A diagnosis of pre-existing lung disease including congenital abnormalities, full or partial pneumonectomy, or previous therapeutic radiation of lungs or mediastinum.
Body mass index (BMI) \>45 kg/m² at screening.
Clareo Health | Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
